<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药信息新药开发 | wechat-feeds</title><link>http://MjM5MDk5MjU4NQ.favicon.privacyhide.com/favicon.ico</link><description>注册、BD、新药立项、研发、市场动态和竞争分析等。</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 04 Mar 2021 11:23:30 +0800</pubDate><image><url>http://MjM5MDk5MjU4NQ.favicon.privacyhide.com/favicon.ico</url><title>医药信息新药开发 | wechat-feeds</title><link>http://MjM5MDk5MjU4NQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>多动症新药：FDA批准KEMPHARM公司的Azstarys™</title><link>https://mp.weixin.qq.com/s/Ll5_9psxHmpPROGPBVlzoQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FAWk7vBjg6HHzjOFgfwAY5ican1gTkyEwqKy8xDh4btqSWmZU2RtKzRWJJLM3m79iclqQQzbyKcgt43I7jtwcUnQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>多动症新药！]]></content:encoded><pubDate>Thu, 04 Mar 2021 08:35:28 +0800</pubDate></item><item><title>第四届新药仿药研发交流论坛-更新-2</title><link>https://mp.weixin.qq.com/s/KElzW9w0r7jOXG0cbXliTQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FAWk7vBjg6GDuwgMrp80icWDYcEdB7pT6Ncra8Vwns3FX6rChOMYZzxcbb0ENicTGXTKaJfmfKahtCX7OpzELygQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>第四届论坛-更新-2]]></content:encoded><pubDate>Tue, 02 Mar 2021 21:33:37 +0800</pubDate></item><item><title>橙皮书系列之市场独占权（4）——首仿药的180天市场独占期</title><link>https://mp.weixin.qq.com/s/KUTGx5pSbJ4cBcQuPon-Vw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FAWk7vBjg6G3HL3RszYYKpjaB9zHHtszulQWrMYvus7HqygcVrXKqcvic0bgzZa0mvR9jRk7JkSRRWHORQnxJBw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>独占权的最后一篇]]></content:encoded><pubDate>Mon, 01 Mar 2021 08:02:40 +0800</pubDate></item><item><title>罕见病日大礼包，FDA批准治疗DMD核酸新药</title><link>https://mp.weixin.qq.com/s/gjQZnJFlyBuIISo1lKpSXA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FAWk7vBjg6G8NvUgOWaJTU6zlbfGS8iavh4y7hpDibTlcJYCM2WeFbzLlBTI0ibX4lhIXWDPgJKpfzvcu0TWLBrAg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>杜氏肌营养不良症新药]]></content:encoded><pubDate>Fri, 26 Feb 2021 10:05:52 +0800</pubDate></item><item><title>国家药监局附条件批准两家公司新冠疫苗注册申请</title><link>https://mp.weixin.qq.com/s/zBVxACgVoAksggEvy4Tcng</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FAWk7vBjg6F4dUg0gxGK5ldicaCVt9NKahywFKOPLLiaUGmx1ia7CqN2xUKTypWSF9f4qFibQaTpibgxrPFjFUKkqZw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>武生所及康希诺新冠疫苗获得批准]]></content:encoded><pubDate>Thu, 25 Feb 2021 20:46:41 +0800</pubDate></item></channel></rss>